Subscribe To
sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting
– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...
November 3, 2023, 8:05 pm
sensei biotherapeutics appoints stephanie krebs, ms, mba, as chief business officer
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) — sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stag...
November 1, 2023, 11:30 am
sensei biotherapeutics to present initial clinical data from dose escalation trial of sns-101 at 2023 sitc annual meeting
BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage...
October 25, 2023, 9:05 am
sensei biotherapeutics to present new preclinical data supporting mechanism of action, pharmacokinetic profile and safety characteristics for sns-101, a conditionally active vista-blocking antibody, a
BOSTON, Sept. 13, 2023 (GLOBE NEWSWIRE) — sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical sta...
September 13, 2023, 11:30 am
Adobe: buy the bullish momentum (technical analysis)
Adobe's strategic move into AI for content creation has strengthened bullish sentiment surrounding the stock, with the introduction of AI-driven tools...
June 11, 2023, 11:15 am
Adobe (adbe) boosts experience cloud with new innovations
Adobe (ADBE) introduces the latest generative AI innovations in Adobe sensei GenAI to aid businesses in...
June 9, 2023, 11:27 am
sensei biotherapeutics to participate in jefferies global healthcare conference
BOSTON, May 31, 2023 (GLOBE NEWSWIRE) — sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage...
May 31, 2023, 11:30 am
sensei biotherapeutics presents new preclinical data on sns-103 targeting entpdase1 (cd39) at the american association for cancer research (aacr) annual meeting 2023
BOSTON, April 18, 2023 (GLOBE NEWSWIRE) — sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-onco...
April 18, 2023, 8:05 pm
Adobe launches generative ai tools aimed at marketers
Coinciding with the launch of its Firefly family of generative AI models, Adobe today unveiled Adobe sensei...
March 21, 2023, 9:00 am
sensei biotherapeutics to present new preclinical data for sns-101, a conditionally active vista-blocking antibody, at the keystone symposia on next generation antibody therapeutics
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncolo...
February 14, 2023, 7:30 am